These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 18226269

  • 1. Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis.
    Shankar S, Ganapathy S, Chen Q, Srivastava RK.
    Mol Cancer; 2008 Jan 29; 7():16. PubMed ID: 18226269
    [Abstract] [Full Text] [Related]

  • 2. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.
    Shankar S, Davis R, Singh KP, Kurzrock R, Ross DD, Srivastava RK.
    Mol Cancer Ther; 2009 Jun 29; 8(6):1596-605. PubMed ID: 19509267
    [Abstract] [Full Text] [Related]

  • 3. MS-275 sensitizes TRAIL-resistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo.
    Srivastava RK, Kurzrock R, Shankar S.
    Mol Cancer Ther; 2010 Dec 29; 9(12):3254-66. PubMed ID: 21041383
    [Abstract] [Full Text] [Related]

  • 4. Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor.
    Ganapathy S, Chen Q, Singh KP, Shankar S, Srivastava RK.
    PLoS One; 2010 Dec 28; 5(12):e15627. PubMed ID: 21209944
    [Abstract] [Full Text] [Related]

  • 5. Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis.
    Shankar S, Ganapathy S, Srivastava RK.
    Clin Cancer Res; 2008 Nov 01; 14(21):6855-66. PubMed ID: 18980980
    [Abstract] [Full Text] [Related]

  • 6. Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation.
    Deeb D, Jiang H, Gao X, Hafner MS, Wong H, Divine G, Chapman RA, Dulchavsky SA, Gautam SC.
    Mol Cancer Ther; 2004 Jul 01; 3(7):803-12. PubMed ID: 15252141
    [Abstract] [Full Text] [Related]

  • 7. Diallyl trisulfide increases the effectiveness of TRAIL and inhibits prostate cancer growth in an orthotopic model: molecular mechanisms.
    Shankar S, Chen Q, Ganapathy S, Singh KP, Srivastava RK.
    Mol Cancer Ther; 2008 Aug 01; 7(8):2328-38. PubMed ID: 18723480
    [Abstract] [Full Text] [Related]

  • 8. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
    Deeb D, Jiang H, Gao X, Al-Holou S, Danyluk AL, Dulchavsky SA, Gautam SC.
    J Pharmacol Exp Ther; 2007 May 01; 321(2):616-25. PubMed ID: 17289836
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis.
    Shankar S, Chen Q, Sarva K, Siddiqui I, Srivastava RK.
    J Mol Signal; 2007 Oct 04; 2():10. PubMed ID: 17916240
    [Abstract] [Full Text] [Related]

  • 11. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF, Chen HL, Liu CY, Tai WT, Ichikawa K, Chen PJ, Cheng AL.
    Biochem Pharmacol; 2012 Mar 15; 83(6):769-77. PubMed ID: 22230479
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo.
    Shankar S, Chen X, Srivastava RK.
    Prostate; 2005 Feb 01; 62(2):165-86. PubMed ID: 15389801
    [Abstract] [Full Text] [Related]

  • 14. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.
    Shankar S, Singh TR, Srivastava RK.
    Prostate; 2004 Sep 15; 61(1):35-49. PubMed ID: 15287092
    [Abstract] [Full Text] [Related]

  • 15. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.
    Kunnumakkara AB, Diagaradjane P, Anand P, Harikumar KB, Deorukhkar A, Gelovani J, Guha S, Krishnan S, Aggarwal BB.
    Int J Cancer; 2009 Nov 01; 125(9):2187-97. PubMed ID: 19623659
    [Abstract] [Full Text] [Related]

  • 16. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S, Almasan A.
    Cancer Res; 2003 Aug 01; 63(15):4713-23. PubMed ID: 12907654
    [Abstract] [Full Text] [Related]

  • 17. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
    Siddiqui IA, Malik A, Adhami VM, Asim M, Hafeez BB, Sarfaraz S, Mukhtar H.
    Oncogene; 2008 Mar 27; 27(14):2055-63. PubMed ID: 17998943
    [Abstract] [Full Text] [Related]

  • 18. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.
    Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347
    [Abstract] [Full Text] [Related]

  • 19. Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF-kappaB and upregulation of TRAIL receptors.
    Kamat AM, Tharakan ST, Sung B, Aggarwal BB.
    Cancer Res; 2009 Dec 01; 69(23):8958-66. PubMed ID: 19903839
    [Abstract] [Full Text] [Related]

  • 20. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5).
    Jung EM, Lim JH, Lee TJ, Park JW, Choi KS, Kwon TK.
    Carcinogenesis; 2005 Nov 01; 26(11):1905-13. PubMed ID: 15987718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.